Ribometrix
Kevin Weeks has worked at the University of North Carolina at Chapel Hill since 2011, where they have held the role of Kenan Distinguished Professor of Chemistry. In 2014, they became an Academic Founder at Ribometrix.
Kevin Weeks has a varied educational background. Kevin has a BA in Chemistry from The College of Wooster, a PhD in Biophysical Chemistry from Yale University, a Postdoc in Biochemistry from the University of Colorado Boulder, and they are currently a Visiting Fellow at Clare Hall at the University of Cambridge.
This person is not in any teams
Ribometrix
Ribometrix, headquartered in Durham, North Carolina, is a biotechnology company leveraging world-leading expertise in three-dimensional structural analysis of RNA as the foundation of its proprietary drug discovery platform. This platform enables the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease. Ribometrix’ value creation strategy is built around developing an internal pipeline of drug candidates and partnerships with the leading biopharmaceutical companies. Ribometrix is backed by a syndicate of blue-chip venture investors.